• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑癌蛋白 p53 调控造血干细胞命运。

The p53 tumor suppressor protein regulates hematopoietic stem cell fate.

机构信息

Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

出版信息

J Cell Physiol. 2011 Sep;226(9):2215-21. doi: 10.1002/jcp.22561.

DOI:10.1002/jcp.22561
PMID:21660944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3081536/
Abstract

The p53 tumor suppressor protein is a key transcription factor that regulates several signaling pathways involved in the cell's response to stress. Through stress-induced activation, p53 accumulates and triggers the expression of target genes that protect the genetic integrity of all cells including hematopoietic stem cells (HSCs). These protective mechanisms include cell-cycle arrest, DNA repair, induction of apoptosis, or initiation of senescence. In addition to its function under stress conditions, p53 has important functions during steady-state hematopoiesis, regulating HSC quiescence and self-renewal. In addition, it appears that p53 levels affect HSC competition for the hematopoietic niche, with the less p53 activated HSCs preferentially surviving. The specific genes and precise mechanisms underlying p53's effects on normal HSCs are slowly being clarified. p53 also plays an important role in leukemia stem cell (LSC) behavior, with p53 loss affecting drug resistance and disease progression. Pharmacologic activation of p53 function could overcome the adverse impact of p53 inactivation in LSCs. Thus, understanding the p53 regulatory mechanisms active in HSCs and LSCs may promote the development of new therapeutic strategies that could eliminate the population of largely quiescent LSCs.

摘要

p53 肿瘤抑制蛋白是一种关键的转录因子,可调节细胞对应激反应的几种信号通路。通过应激诱导激活,p53 积累并触发靶基因的表达,从而保护所有细胞(包括造血干细胞 [HSCs])的遗传完整性。这些保护机制包括细胞周期停滞、DNA 修复、诱导细胞凋亡或启动衰老。除了在应激条件下的功能外,p53 在稳态造血过程中也具有重要功能,调节 HSC 静止和自我更新。此外,似乎 p53 水平会影响 HSC 对造血龛的竞争,其中激活较少的 p53 的 HSC 更优先存活。p53 对正常 HSC 的影响的具体基因和精确机制正在慢慢阐明。p53 在白血病干细胞(LSC)行为中也起着重要作用,p53 的缺失会影响药物耐药性和疾病进展。p53 功能的药理学激活可以克服 LSCs 中 p53 失活的不利影响。因此,了解 HSCs 和 LSCs 中 p53 的调节机制可能会促进开发新的治疗策略,以消除大部分静止的 LSC 群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c41/3081536/5cb1ca27090f/nihms260448f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c41/3081536/0c94f4dd46d3/nihms260448f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c41/3081536/5cb1ca27090f/nihms260448f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c41/3081536/0c94f4dd46d3/nihms260448f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c41/3081536/5cb1ca27090f/nihms260448f2.jpg

相似文献

1
The p53 tumor suppressor protein regulates hematopoietic stem cell fate.抑癌蛋白 p53 调控造血干细胞命运。
J Cell Physiol. 2011 Sep;226(9):2215-21. doi: 10.1002/jcp.22561.
2
The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior.p53 肿瘤抑制蛋白是造血干细胞行为的关键调节因子。
Cell Cycle. 2009 Oct 1;8(19):3120-4. doi: 10.4161/cc.8.19.9627.
3
Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.Necdin 是 p53 的一个靶基因,调节造血干/祖细胞的静止和对遗传毒性应激的反应。
Blood. 2012 Aug 23;120(8):1601-12. doi: 10.1182/blood-2011-11-393983. Epub 2012 Jul 9.
4
p53 regulates hematopoietic stem cell quiescence.p53调节造血干细胞的静止状态。
Cell Stem Cell. 2009 Jan 9;4(1):37-48. doi: 10.1016/j.stem.2008.11.006.
5
Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.造血干细胞和白血病干细胞对Tcf1和Lef1转录因子有不同的依赖性。
J Biol Chem. 2016 May 20;291(21):11148-60. doi: 10.1074/jbc.M116.717801. Epub 2016 Apr 4.
6
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.人类造血干细胞中独特的 DNA 损伤反应揭示了 p53 在自我更新中凋亡独立的作用。
Cell Stem Cell. 2010 Aug 6;7(2):186-97. doi: 10.1016/j.stem.2010.05.016. Epub 2010 Jul 8.
7
[Maintenance of hematopoietic stem cell integrity and regulation of leukemogenesis by p53 and its coactivator Aspp1].[p53及其共激活因子Aspp1对造血干细胞完整性的维持及白血病发生的调控]
Rinsho Ketsueki. 2015 Dec;56(12):2426-33. doi: 10.11406/rinketsu.56.2426.
8
Regulation of hematopoietic and leukemic stem cells by the immune system.免疫系统对造血干细胞和白血病干细胞的调控。
Cell Death Differ. 2015 Feb;22(2):187-98. doi: 10.1038/cdd.2014.89. Epub 2014 Jul 4.
9
Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.单细胞基因表达分析揭示急性髓系白血病白血病干细胞隔间中具有不同自我更新和增殖能力的亚群。
Cancer Res. 2020 Feb 1;80(3):458-470. doi: 10.1158/0008-5472.CAN-18-2932. Epub 2019 Nov 29.
10
Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.MYSM1对p53靶基因Bbc3/PUMA的抑制作用对于造血多能祖细胞的存活至关重要,并有助于干细胞维持。
Cell Death Differ. 2016 May;23(5):759-75. doi: 10.1038/cdd.2015.140. Epub 2016 Jan 15.

引用本文的文献

1
The E3 ubiquitin ligase Cul5 regulates hematopoietic stem cell function for steady-state hematopoiesis in mice.E3泛素连接酶Cul5调节小鼠稳态造血过程中的造血干细胞功能。
J Clin Invest. 2025 Jun 26;135(17). doi: 10.1172/JCI180913. eCollection 2025 Sep 2.
2
Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild type.突变型p53通过一种与野生型共享的基因组占据模式来调控一组独特的基因。
EMBO Rep. 2025 Mar;26(5):1315-1343. doi: 10.1038/s44319-025-00375-y. Epub 2025 Jan 28.
3
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells.

本文引用的文献

1
Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis.造血干细胞静止促进易错 DNA 修复和突变。
Cell Stem Cell. 2010 Aug 6;7(2):174-85. doi: 10.1016/j.stem.2010.06.014. Epub 2010 Jul 8.
2
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice.一种 p53 的小分子抑制剂可刺激造血干细胞的扩增,但不会促进小鼠肿瘤的发展。
Cell Cycle. 2010 Apr 1;9(7):1434-43. doi: 10.4161/cc.9.7.11508.
3
p53-mediated hematopoietic stem and progenitor cell competition.
酪氨酸激酶抑制剂疗法可增强干细胞特征,并可能有助于慢性髓性白血病干细胞的存活。
J Clin Med. 2025 Jan 10;14(2):392. doi: 10.3390/jcm14020392.
4
Hematopoietic stem cell metabolism within the bone marrow niche - insights and opportunities.骨髓微环境中的造血干细胞代谢——见解与机遇
Bioessays. 2025 Feb;47(2):e2400154. doi: 10.1002/bies.202400154. Epub 2024 Nov 6.
5
Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.急性红细胞白血病:从分子生物学到临床结局。
Int J Mol Sci. 2024 Jun 6;25(11):6256. doi: 10.3390/ijms25116256.
6
p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice.p53 调控小鼠内源性 DNA 损伤的多种组织特异性效应。
Nat Commun. 2024 Mar 21;15(1):2518. doi: 10.1038/s41467-024-46844-1.
7
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity.MDM2抑制剂RG7388与I类组蛋白去乙酰化酶抑制剂恩替诺特的纳米包封通过协同抗肿瘤作用和降低全身毒性增强了它们的治疗潜力。
Mol Pharm. 2024 Mar 4;21(3):1246-1255. doi: 10.1021/acs.molpharmaceut.3c00926. Epub 2024 Feb 9.
8
Efficient expansion and delayed senescence of hUC-MSCs by microcarrier-bioreactor system.微载体-生物反应器系统高效扩增及延缓 hUC-MSCs 衰老。
Stem Cell Res Ther. 2023 Oct 4;14(1):284. doi: 10.1186/s13287-023-03514-1.
9
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer.代谢失调与癌症表观遗传学的相互作用
Biomolecules. 2023 Jun 5;13(6):944. doi: 10.3390/biom13060944.
10
Cell quiescence in planarian stem cells, interplay between p53 and nutritional stimuli.秀丽隐杆线虫干细胞的细胞静止,p53 与营养刺激之间的相互作用。
Open Biol. 2022 Dec;12(12):220216. doi: 10.1098/rsob.220216. Epub 2022 Dec 21.
p53 介导的造血干/祖细胞竞争。
Cell Stem Cell. 2010 Apr 2;6(4):309-322. doi: 10.1016/j.stem.2010.03.002.
4
Cell competition: pirates on the tangled bank.细胞竞争:纠结之岸的海盗。
Cell Stem Cell. 2010 Apr 2;6(4):287-288. doi: 10.1016/j.stem.2010.03.006.
5
Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation.凋亡促进蛋白 Puma 的缺失选择性地保护造血干细胞和祖细胞免受大剂量辐射。
Blood. 2010 Jun 10;115(23):4707-14. doi: 10.1182/blood-2009-10-248872. Epub 2010 Apr 1.
6
Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.丝裂原活化蛋白激酶/细胞外信号调节激酶激酶阻断与鼠双微体 2 协同通过 BH3 仅蛋白 Puma 和 Bim 诱导急性髓系白血病细胞凋亡。
Cancer Res. 2010 Mar 15;70(6):2424-34. doi: 10.1158/0008-5472.CAN-09-0878. Epub 2010 Mar 9.
7
Irradiation selects for p53-deficient hematopoietic progenitors.辐照选择缺乏 p53 的造血祖细胞。
PLoS Biol. 2010 Mar 2;8(3):e1000324. doi: 10.1371/journal.pbio.1000324.
8
Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation.Puma 的缺失可保护造血干细胞,并赋予其在大剂量 γ 射线辐射下的长期存活能力。
Blood. 2010 Apr 29;115(17):3472-80. doi: 10.1182/blood-2009-10-248278. Epub 2010 Feb 22.
9
Cyclin C regulates human hematopoietic stem/progenitor cell quiescence.周期蛋白 C 调控人类造血干/祖细胞静止。
Stem Cells. 2010 Feb;28(2):308-17. doi: 10.1002/stem.270.
10
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.p53 依赖性机制是人类 5q-综合征小鼠模型中巨红细胞贫血的基础。
Nat Med. 2010 Jan;16(1):59-66. doi: 10.1038/nm.2063. Epub 2009 Nov 22.